본문 바로가기

Prognostic Significance of Tumor Location in T2 Gallbladder Cancer: A Korea Tumor Registry System Biliary Pancreas (KOTUS-BP) Database Analysis

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1
저널
JOURNAL OF CLINICAL MEDICINE9(10) · 2020
피인용
Web of Science 14Scopus 19
FWCI (Scopus)
0
JCR IF
JCR 2019 3.303
ISSN
2077-0383

저자

  1. Lee, Seung Eun제1저자Department of Surgery, Chung-Ang University College of Medicine, Seoul, 06973, Korea;
  2. Choi, Yoo ShinDepartment of Surgery, Chung-Ang University College of Medicine, Seoul, 06973, Korea;
  3. Kim, Yong HoonDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Keimyung University Dongsan Medical Center, Daegu, 42601, Korea
  4. Heo, Jin SeokDepartment of Surgery, Samsung Medical Center, Sungkyunkwan University College of Medicine, Seoul, 06351, Korea;
  5. Jeong, Chi-YoungDepartment of Surgery, Gyeongsang National University College of Medicine, Jinju, 52727, Korea
  6. Lee, Woo JungDepartment of Surgery, Yonsei University College of Medicine, Seoul, 03722, Korea
  7. 서형일Department of Surgery, Biomedical Research Institute, Pusan National University Hospital, Pusan, 49241, Korea
  8. Yoon, Yoo-SeokDepartment of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, 13620, Korea;
  9. Jang, Jin-Young교신저자Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, 03080, Korea

초록

Background: T2 gallbladder cancer (GBC) is subdivided into T2a and T2b by the American Joint Committee on Cancer (AJCC) 8th edition. However; there is a lack of evidence for the prognostic significance of tumor location and validation with large-scale studies is needed. The aims of this study were to investigate the clinical features and clinical outcomes of T2 GBC according to tumor location and determine the prognostic significance of tumor location and an appropriate surgical strategy. Methods: Between 2000 and 2014 the Korea Tumor Registry System Biliary Pancreas (KOTUS-BP) database was used to identify and enroll a total 707 patients with pathologically diagnosed T2 GBC who underwent curative resection. Clinicopathological findings and long-term follow-up results were analyzed. Results: The incidence of lymph node metastasis in T2b was significantly higher than that of T2a tumors (37.9% vs. 29.5%, p = 0.032). The 5-year disease-specific survival of T2a was better than that of T2b tumors (74.8% vs. 65.4%, p = 0.019). There was no significant survival difference in T2a between extended cholecystectomy and simple cholecystectomy with lymph node dissection (81.8% vs. 73.7%, p = 0.361). However; there was a better survival trend for T2b tumor after extended cholecystectomy (71.7% vs. 59.3%, p = 0.057). Adjuvant chemotherapy was associated with improved survival for patients with lymph node metastasis in T2a (72.1% vs. 56.9; p = 0.022) and in T2b (68.2 vs. 48.5; p < 0.001). Multivariate analysis revealed that lymph node metastasis was the only significant poor prognostic factor (Hazard ratio 3.222; 95% confidential interval 1.960-4.489; p < 0.001). Conclusions: For T2 GBC; tumor location was not an independent prognostic factor. Lymph node metastasis was a significant poor prognostic factor and adjuvant chemotherapy should be considered for the patients with lymph node metastasis.

키워드

gallbladdercarcinomaperitonealhepaticprognosisPHASE-IIRESECTIONGEMCITABINESURVIVALCHOLANGIOCARCINOMAGUIDELINESEXTENTTRIALTRACT

식별자

Scopus EID
2-s2.0-85103496736
WoS UID
000586856800001